NL194154C - Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat. - Google Patents
Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat. Download PDFInfo
- Publication number
- NL194154C NL194154C NL8701744A NL8701744A NL194154C NL 194154 C NL194154 C NL 194154C NL 8701744 A NL8701744 A NL 8701744A NL 8701744 A NL8701744 A NL 8701744A NL 194154 C NL194154 C NL 194154C
- Authority
- NL
- Netherlands
- Prior art keywords
- nac
- aspartame
- sorbitol
- granulate
- weight
- Prior art date
Links
- PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 title claims description 38
- 229960004308 acetylcysteine Drugs 0.000 title claims description 26
- 238000002360 preparation method Methods 0.000 title claims description 23
- 108010011485 Aspartame Proteins 0.000 title claims description 19
- 239000000605 aspartame Substances 0.000 title claims description 19
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 title claims description 19
- 235000010357 aspartame Nutrition 0.000 title claims description 19
- 229960003438 aspartame Drugs 0.000 title claims description 19
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 claims description 17
- 239000000203 mixture Substances 0.000 claims description 17
- 239000000600 sorbitol Substances 0.000 claims description 17
- 239000008187 granular material Substances 0.000 claims description 16
- 239000000796 flavoring agent Substances 0.000 claims description 11
- 235000019634 flavors Nutrition 0.000 claims description 11
- 239000003086 colorant Substances 0.000 claims description 7
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 claims description 7
- 239000007968 orange flavor Substances 0.000 claims description 7
- 239000000243 solution Substances 0.000 claims description 6
- 239000004173 sunset yellow FCF Substances 0.000 claims description 5
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 claims description 4
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- 239000004698 Polyethylene Substances 0.000 claims description 3
- 229920000573 polyethylene Polymers 0.000 claims description 3
- 239000000126 substance Substances 0.000 claims description 3
- 239000007864 aqueous solution Substances 0.000 claims description 2
- 238000000034 method Methods 0.000 claims 2
- -1 aluminum-polyethylene Chemical group 0.000 claims 1
- 239000008240 homogeneous mixture Substances 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
- 229930006000 Sucrose Natural products 0.000 description 7
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
- 239000005720 sucrose Substances 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 238000009472 formulation Methods 0.000 description 5
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 5
- 235000003599 food sweetener Nutrition 0.000 description 4
- 244000248349 Citrus limon Species 0.000 description 3
- 235000005979 Citrus limon Nutrition 0.000 description 3
- 208000002925 dental caries Diseases 0.000 description 2
- 239000000576 food coloring agent Substances 0.000 description 2
- 239000007967 peppermint flavor Substances 0.000 description 2
- 230000014860 sensory perception of taste Effects 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 235000021092 sugar substitutes Nutrition 0.000 description 2
- 241000207199 Citrus Species 0.000 description 1
- 235000008733 Citrus aurantifolia Nutrition 0.000 description 1
- UIIMBOGNXHQVGW-DEQYMQKBSA-M Sodium bicarbonate-14C Chemical compound [Na+].O[14C]([O-])=O UIIMBOGNXHQVGW-DEQYMQKBSA-M 0.000 description 1
- 235000011941 Tilia x europaea Nutrition 0.000 description 1
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- 239000008122 artificial sweetener Substances 0.000 description 1
- 235000021311 artificial sweeteners Nutrition 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 229940109275 cyclamate Drugs 0.000 description 1
- HCAJEUSONLESMK-UHFFFAOYSA-N cyclohexylsulfamic acid Chemical compound OS(=O)(=O)NC1CCCCC1 HCAJEUSONLESMK-UHFFFAOYSA-N 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 239000007938 effervescent tablet Substances 0.000 description 1
- 239000004571 lime Substances 0.000 description 1
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 1
- 230000000510 mucolytic effect Effects 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 235000021309 simple sugar Nutrition 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 239000000811 xylitol Substances 0.000 description 1
- 235000010447 xylitol Nutrition 0.000 description 1
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 1
- 229960002675 xylitol Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
- A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH297486 | 1986-07-24 | ||
| CH2974/86A CH666814A5 (it) | 1986-07-24 | 1986-07-24 | Composizione farmaceutica idrosolubile contenente n-acetil-cisteina. |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| NL8701744A NL8701744A (nl) | 1988-02-16 |
| NL194154B NL194154B (nl) | 2001-04-02 |
| NL194154C true NL194154C (nl) | 2001-08-03 |
Family
ID=4245819
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NL8701744A NL194154C (nl) | 1986-07-24 | 1987-07-23 | Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat. |
Country Status (8)
| Country | Link |
|---|---|
| BE (1) | BE1000168A3 (it) |
| CH (1) | CH666814A5 (it) |
| DE (1) | DE3723734A1 (it) |
| FR (1) | FR2601875B1 (it) |
| GB (1) | GB2192789B (it) |
| IT (1) | IT1222103B (it) |
| NL (1) | NL194154C (it) |
| SE (1) | SE500493C2 (it) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1217445B (it) * | 1988-04-29 | 1990-03-22 | Altergon Sa | Composizione farmaceutiche orosolubili contenti acetilcisteina |
| CH674940A5 (it) * | 1988-05-05 | 1990-08-15 | Ibsa Inst Biochimique Sa | |
| DE3909049A1 (de) * | 1989-03-18 | 1990-09-20 | Arthur Boskamp | Praeparat und dessen verwendung |
| US5296500A (en) * | 1991-08-30 | 1994-03-22 | The Procter & Gamble Company | Use of N-acetyl-cysteine and derivatives for regulating skin wrinkles and/or skin atrophy |
| IT1256616B (it) * | 1992-12-02 | 1995-12-12 | Zambon Spa | Sciroppo contenente n-acetil-cisteina |
| GB9226729D0 (en) * | 1992-12-22 | 1993-02-17 | Wellcome Found | Therapeutic combination |
| DE4406261C2 (de) * | 1993-08-31 | 1996-07-04 | Deutsches Krebsforsch | Verwendung von Thiolverbindungen zur Verminderung der Körperfettmenge |
| DE4329857C2 (de) * | 1993-09-03 | 1995-08-24 | Deutsches Krebsforsch | Verbindung zur Stärkung des Immunsystems und von Immunreaktionen |
| BE1007926A3 (fr) * | 1994-01-31 | 1995-11-21 | Zambon Int Pharma | Composition pharmaceutique contenant de la n-acetyl-cysteine. |
| US5451405A (en) * | 1994-04-25 | 1995-09-19 | Chesebrough-Pond's Usa Co. | Skin treatment composition |
| WO2000018392A1 (en) * | 1998-09-25 | 2000-04-06 | Glycox Corporation Limited | Fructosamine oxidase: antagonists and inhibitors |
| CN1320160A (zh) | 1998-09-25 | 2001-10-31 | 格利科克斯有限公司 | 果糖胺氧化酶测定的方法和材料 |
| EP1293251A1 (en) * | 2001-09-14 | 2003-03-19 | Holland Sweetener Company V.o.F. | Process for the production of alpha-L-aspartyl-l-phenylalanine methyl ester powder |
| EP2500018B1 (en) | 2002-03-08 | 2017-07-19 | PhilERA New Zealand Limited | Preventing and/or Treating Cardiovascular Disease and/or Associated Heart Failure |
| US20060100278A1 (en) | 2002-08-20 | 2006-05-11 | Cooper Garth J S | Dosage forms and related therapies |
| CA2875095C (en) | 2004-07-19 | 2019-09-03 | Philera New Zealand Limited | Synthesis of triethylenetetramines |
| GR1007236B (el) * | 2009-12-07 | 2011-04-08 | Uni-Pharma Κλεων Τσετης Φαρμακευτικα Εργαστηρια Αβεε Με Δ.Τ. Uni-Pharma Abee, | Νεα φαρμακευτικη συνθεση κοκκιων ν - ακετυλοκυστεϊνης και μεθοδος παραγωγης αυτων |
| IT1399492B1 (it) * | 2010-04-13 | 2013-04-19 | Alpex Pharma Sa | Composizioni farmaceutiche effervescenti contenenti n-acetilcisteina. |
| CN103142505B (zh) * | 2013-03-29 | 2015-03-11 | 山东罗欣药业集团股份有限公司 | 一种乙酰半胱氨酸组合物颗粒剂及其制备方法 |
| ES2877679T3 (es) | 2017-12-31 | 2021-11-17 | Abdi Ibrahim Ilac Sanayi Ve Ticaret A S | Composición farmacéutica que comprende acetilcitisteína sin metilparabeno ni propilparabeno |
| CN113559078A (zh) * | 2021-07-02 | 2021-10-29 | 安徽省先锋制药有限公司 | 一种乙酰半胱氨酸泡腾片的制备方法 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE1617638A1 (de) * | 1967-05-24 | 1971-05-13 | Miles Lab | Tablettenbindemittel |
| CH646843A5 (en) * | 1982-02-17 | 1984-12-28 | Xyrofin Ag | Sugar substitute, method for its production, and its use |
| AU574360B2 (en) * | 1983-05-13 | 1988-07-07 | Reichert, D. | Antisnoring agent |
| DE3317530A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Antischnarchmittel |
| DE3317558A1 (de) * | 1983-05-13 | 1984-11-15 | Dietrich Dr.med. Sta. Eulalia Ibiza Reichert | Orales antischnarchmittel |
| IT1170268B (it) * | 1983-12-21 | 1987-06-03 | Zambon Spa | Uso dell'acetilcisteina per ridurre l'incremento della prolieferazione delle cellule basali dell'epitelio respiratoriotracheo-bronchiale indotto dal fumo di tabacco nei mammiferi |
| DE3514995A1 (de) * | 1985-04-25 | 1986-10-30 | Protopharma Ltd., 7831 Malterdingen | Verwendung von sulfydrylarzneimitteln zur bekaempfung von schaedigungen der magenschleimhaut |
-
1986
- 1986-07-24 CH CH2974/86A patent/CH666814A5/it not_active IP Right Cessation
-
1987
- 1987-07-17 DE DE19873723734 patent/DE3723734A1/de active Granted
- 1987-07-22 FR FR878710367A patent/FR2601875B1/fr not_active Expired - Lifetime
- 1987-07-23 NL NL8701744A patent/NL194154C/nl not_active IP Right Cessation
- 1987-07-23 BE BE8700817A patent/BE1000168A3/fr not_active IP Right Cessation
- 1987-07-23 IT IT21410/87A patent/IT1222103B/it active
- 1987-07-23 SE SE8702941A patent/SE500493C2/sv not_active IP Right Cessation
- 1987-07-24 GB GB8717581A patent/GB2192789B/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| GB8717581D0 (en) | 1987-09-03 |
| IT8721410A0 (it) | 1987-07-23 |
| NL194154B (nl) | 2001-04-02 |
| FR2601875A1 (fr) | 1988-01-29 |
| CH666814A5 (it) | 1988-08-31 |
| BE1000168A3 (fr) | 1988-07-05 |
| SE8702941D0 (sv) | 1987-07-23 |
| GB2192789A (en) | 1988-01-27 |
| SE500493C2 (sv) | 1994-07-04 |
| DE3723734A1 (de) | 1988-02-04 |
| FR2601875B1 (fr) | 1992-02-21 |
| IT1222103B (it) | 1990-08-31 |
| NL8701744A (nl) | 1988-02-16 |
| SE8702941L (sv) | 1988-01-25 |
| GB2192789B (en) | 1990-01-31 |
| DE3723734C2 (it) | 1992-05-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NL194154C (nl) | Farmaceutisch wateroplosbaar preparaat dat N-acetylcysteine en aspartame bevat. | |
| NL194067C (nl) | Farmaceutisch wateroplosbaar bruispreparaat dat N-acetylcysteine en aspartame bevat. | |
| CA1329130C (en) | Ranitidine | |
| RU2184570C2 (ru) | Препараты для орального введения | |
| US4689233A (en) | Coronary therapeutic agent in the form of soft gelatin capsules | |
| US9034382B2 (en) | Oseltamivir phosphate granule and preparation method thereof | |
| US20060024335A1 (en) | Oral compositions which mask the bitter taste of a bitter-tasting agent | |
| EP0481294B1 (de) | Feste, schnell-lösliche Arzneimittelzubereitung enthaltend S-(Carboxymethyl)-L-Cystein und/oder N-Acetylcystein | |
| JPH02164820A (ja) | イブプロフェン風味マスク法 | |
| HU229793B1 (en) | Fizzy formulations | |
| KR20100135316A (ko) | 감칠맛을 가진 디페리프론용 액상 제제 | |
| CA2254144C (en) | Pharmaceutical compositions based on diclofenac | |
| EP0340662B1 (en) | Solid, water-soluble, pharmaceutical composition containing acetylcysteine | |
| US20100298242A1 (en) | Masking the taste of compositons containing salt | |
| US6399099B1 (en) | Effervescent composition with dry extract of ginkgo biloba | |
| EP0769294B1 (en) | Taste-masked aqueous solutions comprising ibuprofen and menthol | |
| US20170151303A1 (en) | Compositions and Methods for Alleviating Hyposalivation and for Providing Oral Comfort | |
| US6075048A (en) | Pediatric method of use of bambuterol | |
| JP2022525147A (ja) | オーラルケア組成物 | |
| JPH10218748A (ja) | アルコール臭低減剤および飲食物 | |
| WO1996003980A1 (en) | Improved effervescent delivery system | |
| FR2765804A1 (fr) | Composition pharmaceutique d'apport calcique et formes galeniques orales comprenant une telle composition | |
| Eriksson et al. | The influence of the sweetening agent on the oral absorption of penicillin V |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| BA | A request for search or an international-type search has been filed | ||
| BB | A search report has been drawn up | ||
| BC | A request for examination has been filed | ||
| TNT | Modifications of names of proprietors of patents or applicants of examined patent applications |
Owner name: INPHARZAM S.A. |
|
| V4 | Discontinued because of reaching the maximum lifetime of a patent |
Effective date: 20070723 |